| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2535 | 2018 |
| Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline SR Bornstein, B Allolio, W Arlt, A Barthel, A Don-Wauchope, GD Hammer, ... The Journal of Clinical Endocrinology & Metabolism 101 (2), 364-389, 2016 | 1593 | 2016 |
| Adrenocortical carcinoma T Else, AC Kim, A Sabolch, VM Raymond, A Kandathil, EM Caoili, S Jolly, ... Endocrine reviews 35 (2), 282-326, 2014 | 905 | 2014 |
| European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study … M Fassnacht, OM Dekkers, T Else, E Baudin, A Berruti, RR De Krijger, ... European journal of endocrinology 179 (4), G1-G46, 2018 | 771 | 2018 |
| Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression MW Nachtigal, Y Hirokawa, DL Enyeart-VanHouten, JN Flanagan, ... Cell 93 (3), 445-454, 1998 | 697 | 1998 |
| Comprehensive pan-genomic characterization of adrenocortical carcinoma S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ... Cancer cell 29 (5), 723-736, 2016 | 654 | 2016 |
| Pathophysiology of disease: an introduction to clinical medicine GD Hammer, SJ McPhee, MGH Education McGraw-Hill Education Medical, 2014 | 629 | 2014 |
| Management of patients with adrenal cancer: recommendations of an international consensus conference DE Schteingart, GM Doherty, PG Gauger, TJ Giordano, GD Hammer, ... Endocrine-related cancer 12 (3), 667-680, 2005 | 508 | 2005 |
| Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results GD Hammer, JB Tyrrell, KR Lamborn, CB Applebury, ET Hannegan, ... The Journal of Clinical Endocrinology & Metabolism 89 (12), 6348-6357, 2004 | 446 | 2004 |
| Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress GD Hammer, I Krylova, Y Zhang, BD Darimont, K Simpson, NL Weigel, ... Molecular cell 3 (4), 521-526, 1999 | 444 | 1999 |
| Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling TJ Giordano, R Kuick, T Else, PG Gauger, M Vinco, J Bauersfeld, ... Clinical cancer research 15 (2), 668-676, 2009 | 425 | 2009 |
| Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study M Fassnacht, A Berruti, E Baudin, MJ Demeure, J Gilbert, H Haak, ... The lancet oncology 16 (4), 426-435, 2015 | 351 | 2015 |
| Telomere protection by mammalian Pot1 requires interaction with Tpp1 D Hockemeyer, W Palm, T Else, JP Daniels, KK Takai, JZS Ye, ... Nature structural & molecular biology 14 (8), 754-761, 2007 | 271 | 2007 |
| Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma BS Miller, JB Ammori, PG Gauger, JT Broome, GD Hammer, GM Doherty World journal of surgery 34, 1380-1385, 2010 | 258 | 2010 |
| Recent insights into organogenesis of the adrenal cortex CE Keegan, GD Hammer Trends in Endocrinology & Metabolism 13 (5), 200-208, 2002 | 244 | 2002 |
| Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma FM Barlaskar, AC Spalding, JH Heaton, R Kuick, AC Kim, DG Thomas, ... The Journal of Clinical Endocrinology & Metabolism 94 (1), 204-212, 2009 | 237 | 2009 |
| Targeted disruption of β-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex AC Kim, AL Reuter, M Zubair, T Else, K Serecky, NC Bingham, GG Lavery, ... Oxford University Press for The Company of Biologists Limited 135 (15), 2593 …, 2008 | 230 | 2008 |
| Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma P Haluska, F Worden, D Olmos, D Yin, D Schteingart, GN Batzel, ... Cancer chemotherapy and pharmacology 65, 765-773, 2010 | 219 | 2010 |
| Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells JL Garcia-Perez, M Morell, JO Scheys, DA Kulpa, S Morell, CC Carter, ... Nature 466 (7307), 769-773, 2010 | 198 | 2010 |
| Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma T Else, AR Williams, A Sabolch, S Jolly, BS Miller, GD Hammer The Journal of Clinical Endocrinology & Metabolism 99 (2), 455-461, 2014 | 193 | 2014 |
